MichaelJeffrey WildenbergDiamantMD

PubMed

• Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes.
  Smits MM, Tonneijck L, Muskiet MHA, Diamant M, Kramer MHH, Cahen DL, van Raalte DH> ;Diabet. Med.. 2016-06-09
• Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial.
  Smits MM, Tonneijck L, Muskiet MHA, Kramer MHH, Diamant M, Pieters-van den Bos IC, van Raalte DH, Cahen DL> ;Diabetes Obes Metab. 2016-03-01
• Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
  Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Diamant M, Joles JA, van Raalte DH> ;Diabetes Obes Metab. 2016-02-01
• Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans.
  van Bloemendaal L, Veltman DJ, Ten Kulve JS, Groot PFC, Ruhé HG, Barkhof F, Sloan JH, Diamant M, Ijzerman RG> ;Diabetes Obes Metab. 2015-09-01
• Is insulin the most effective injectable antihyperglycaemic therapy?
  Buse, J. B.,Peters, A.,Russell-Jones, D.,Furber, S.,Donsmark, M.,Han, J.,MacConell, L.,Maggs, D.,Diamant, M.> ;Diabetes Obes Metab. 2014 Oct 18
• Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS.
  van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M> ;J. Endocrinol.. 2014-04-01
• Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes.
  van Genugten RE, Möller-Goede DL, van Raalte DH, Diamant M> ;Diabetes Obes Metab. 2013-07-01
• Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or ...
  van Genugten RE, Serné EH, Heymans MW, van Raalte DH, Diamant M> ;Diabetologia. 2013-03-01
• GLP-1 based therapies: differential effects on fasting and postprandial glucose.
  Fineman MS, Cirincione BB, Maggs D, Diamant M> ;Diabetes Obes Metab. 2012-08-01
• Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms.
  van der Zijl NJ, Moors CCM, Goossens GH, Blaak EE, Diamant M> ;Diabetes Obes Metab. 2012-07-01
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Associatio...
  Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR> ;Diabetologia. 2012-06-01
• Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment.
  Fineman MS, Mace KF, Diamant M, Darsow T, Cirincione BB, Booker Porter TK, Kinninger LA, Trautmann ME> ;Diabetes Obes Metab. 2012-06-01
• Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
  Moors CCM, van der Zijl NJ, Diamant M, Blaak EE, Goossens GH> ;Int J Obes (Lond). 2012-05-01
• Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence.
  van Genugten RE, van Raalte DH, Diamant M> ;Diabetes Obes Metab. 2012-02-01
• Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids.
  Hoes JN, van der Goes MC, van Raalte DH, van der Zijl NJ, den Uyl D, Lems WF, Lafeber FPGJ, Jacobs JWG, Welsing PMJ, Diamant M, Bijlsma JWJ> ;Ann. Rheum. Dis.. 2011-11-01
• Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.
  van Raalte DH, Brands M, van der Zijl NJ, Muskiet MH, Pouwels PJW, Ackermans MT, Sauerwein HP, Serlie MJ, Diamant M> ;Diabetologia. 2011-08-01
• Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a ...
  Foley JE, Bunck MC, Möller-Goede DL, Poelma M, Nijpels G, Eekhoff EM, Schweizer A, Heine RJ, Diamant M> ;Diabetologia. 2011-08-01
• Hemodialysis in a Satellite Unit: Clinical Performance Target Attainment and Health-Related Quality of Life.
  Diamant, M.J., Young, A., Gallo, K., Xi, W., Suri, R.S., Garg, A.X., Moist, L.M.> ;Clin J Am Soc Nephrol. 2011 Jul
• Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes.
  Bunck MC, Eliasson B, Cornér A, Heine RJ, Shaginian RM, Taskinen M, Yki-Järvinen H, Smith U, Diamant M> ;Diabetes Obes Metab. 2011-04-01
• Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making.
  Xi, W.,Harwood, L.,Diamant, M. J.,Brown, J. B.,Gallo, K.,Sontrop, J. M.,MacNab, J. J.,Moist, L. M.> ;Nephrol Dial Transplant. 2011 Oct
• Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.
  van der Zijl NJ, Goossens GH, Moors CCM, van Raalte DH, Muskiet MHA, Pouwels PJW, Blaak EE, Diamant M> ;J. Clin. Endocrinol. Metab.. 2011-02-01
• A comparison of quality of life and travel-related factors between in-center and satellite-based hemodialysis patients.
  Diamant, M.J., Harwood, L., Movva, S., Wilson, B., Stitt, L., Lindsay, R.M., Moist, L.M.> ;Clin J Am Soc Nephrol. 2010 Feb
• [New drugs; exenatide and sitagliptin].
  Diamant M, Bunck MCM> ;Ned Tijdschr Geneeskd. 2008-07-26
• [Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].
  Diamant M, Bunck MCM, Heine RJ> ;Ned Tijdschr Geneeskd. 2004-09-25
• Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentrati...
  Alssema, M., El-Harchaoui, K., Schindhelm, R. K., Diamant, M., Nijpels, G., Kostense, P. J., Teerlink, T., Heine, R. J., Dallinga-Thie, G. M., Kuivenhoven, J. A., Dekk...> ;Metabolism. 2010 Jun
• Join now to see all